Journal :   Research Journal of Pharmacy and Technology

Volume No. :   1

Issue No. :  3

Year :  2008

Pages :   155-160

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Poor Bioavailability of Rifampicin- A Global Emergency

Address:   Satish Balkrishna Bhise* and Sevukarajan Mookkan
Department of Biopharmaceutics, Government College of pharmacy, Karad-415124(M.S). India.
* Corresponding Author

The use of Fixed dose combinations (FDCs) of antitubercular drugs in the short course chemotherapy of tuberculosis is being promoted internationally. However poor bioavailability of rifampicin has been perceived as a major bottleneck in successful treatment of tuberculosis. It perhaps is amongst one of the contributory factor which may lead to increasing resistance to anti-tubercular drugs. The present article critically focuses on various probable physical and/or chemical reasons responsible for poor/variable bioavailability of rifampicin in FDC and suggests the various approaches which may be successfully employed to overcome the aforementioned problems associated with rifampicin in FDCs.
Rifampicin, FDC, Bioavailability.
Satish Balkrishna Bhise, Sevukarajan Mookkan. Poor Bioavailability of Rifampicin- A Global Emergency. Research J. Pharm. and Tech. 1(3): July-Sept. 2008; Page 155-160.
[View HTML]      [View PDF]

Visitor's No. :   411092